Cefdinir
- Generic Name
- Cefdinir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H13N5O5S2
- CAS Number
- 91832-40-5
- Unique Ingredient Identifier
- CI0FAO63WC
- Background
Cefdinir, also known as Omnicef, is a semi-synthetic, broad-spectrum antibiotic belonging to the third generation of the cephalosporin class. It has been proven to be effective for the treatment of common bacterial infections in the ear, sinus, throat, lungs, and skin. Cefdinir was approved by the FDA in 1997 to treat a variety of mild to moderate infections...
- Indication
Cefdinir is indicated to treat acute bacterial otitis media, acute maxillary sinusitis, community-acquired (CA) pneumonia, acute bacterial exacerbations of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections in children and adults.
...
- Associated Conditions
- Acute Exacerbation of Chronic Bronchitis (AECB), Acute Exacerbation of Chronic Bronchitis caused by Streptococcus Pneumoniae, Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza, Acute Exacerbations of Chronic Bronchitis caused by Moraxella catarrhalis, Acute exacerbation of chronic bronchitis caused by Haemophilus parainfluenzae, Acute maxillary sinusitis, Acute maxillary sinusitis caused by H. influenzae, Acute maxillary sinusitis caused by M. catarrhalis, Acute maxillary sinusitis caused by Susceptible strains of Streptococcus pneumoniae, Community Acquired Pneumonia (CAP), Community acquired pneumonia caused by Susceptible strains of Streptococcus pneumoniae, Pneumonia due to Haemophilus influenzae (H. influenzae), Streptococcal Pharyngitis, Tonsillitis, Tonsillitis streptococcal, Uncomplicated Skin and Skin Structure Infections, Uncomplicated skin and skin structure infections caused by streptococcus pyogenes, staphylococcus aureus, Acute otitis media caused by M. catarrhalis, Acute otitis media caused by S.pneumoniae, Bacterial otitis media caused by Haemophilus influenzae, Community aquired pneumonia caused by H. parainfluenzae, Community aquired pneumonia caused by M.catarrhalis
- Associated Therapies
- -
Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
- Conditions
- Interventions
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2021-02-03
- Target Recruit Count
- 385
- Registration Number
- NCT02891915
- Locations
- 🇺🇸
University of Alabama - Children's of Alabama - Infectious Diseases/Virology, Birmingham, Alabama, United States
🇺🇸University of Louisville School of Medicine - Norton Children's Hospital - Infectious Diseases, Louisville, Kentucky, United States
🇺🇸Washington University School of Medicine in St. Louis - Infectious Diseases, Saint Louis, Missouri, United States
Effectiveness of Oral Antibiotics in the Treatment of Severe Acute Malnutrition
- Conditions
- Interventions
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2011-07-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 2700
- Registration Number
- NCT01000298
- Locations
- 🇲🇼
St. Louis Nutrition Project, Blantyre, Malawi
Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2008-03-27
- Lead Sponsor
- Abbott
- Target Recruit Count
- 447
- Registration Number
- NCT00645203
A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections
- Conditions
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2007-10-25
- Lead Sponsor
- Abbott
- Target Recruit Count
- 380
- Registration Number
- NCT00234949
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.